These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
Pubmed for Handhelds
PUBMED FOR HANDHELDS
Journal Abstract Search
352 related items for PubMed ID: 18541198
1. High prevalence of iron overload in adult allogeneic hematopoietic cell transplant survivors. Majhail NS, DeFor T, Lazarus HM, Burns LJ. Biol Blood Marrow Transplant; 2008 Jul; 14(7):790-4. PubMed ID: 18541198 [Abstract] [Full Text] [Related]
2. Iron overload in patients receiving allogeneic hematopoietic stem cell transplantation: quantification of iron burden by a superconducting quantum interference device (SQUID) and therapeutic effectiveness of phlebotomy. Busca A, Falda M, Manzini P, D'Antico S, Valfrè A, Locatelli F, Calabrese R, Chiappella A, D'Ardia S, Longo F, Piga A. Biol Blood Marrow Transplant; 2010 Jan; 16(1):115-22. PubMed ID: 19766730 [Abstract] [Full Text] [Related]
3. A prospective study of iron overload management in allogeneic hematopoietic cell transplantation survivors. Majhail NS, Lazarus HM, Burns LJ. Biol Blood Marrow Transplant; 2010 Jun; 16(6):832-7. PubMed ID: 20079863 [Abstract] [Full Text] [Related]
4. Iron overload in hematopoietic cell transplantation. Majhail NS, Lazarus HM, Burns LJ. Bone Marrow Transplant; 2008 Jun; 41(12):997-1003. PubMed ID: 18438425 [Abstract] [Full Text] [Related]
5. Iron overload: predictor of adverse outcome in hematopoietic stem cell transplantation. Sucak GT, Yegin ZA, Ozkurt ZN, Aki SZ, Yağci M. Transplant Proc; 2010 Jun; 42(5):1841-8. PubMed ID: 20620535 [Abstract] [Full Text] [Related]
7. Iron overload adversely affects outcome of allogeneic hematopoietic cell transplantation. Pullarkat V, Blanchard S, Tegtmeier B, Dagis A, Patane K, Ito J, Forman SJ. Bone Marrow Transplant; 2008 Dec; 42(12):799-805. PubMed ID: 18762767 [Abstract] [Full Text] [Related]
8. Iron overload in allogeneic hematopoietic stem cell transplant recipients. Ali S, Pimentel JD, Munoz J, Shah V, McKinnon R, Divine G, Janakiraman N. Arch Pathol Lab Med; 2012 May; 136(5):532-8. PubMed ID: 22540302 [Abstract] [Full Text] [Related]
9. Management of high ferritin in long-term survivors after hematopoietic stem cell transplantation. Brissot E, Savani BN, Mohty M. Semin Hematol; 2012 Jan; 49(1):35-42. PubMed ID: 22221783 [Abstract] [Full Text] [Related]
10. MRI-based liver iron content predicts for nonrelapse mortality in MDS and AML patients undergoing allogeneic stem cell transplantation. Wermke M, Schmidt A, Middeke JM, Sockel K, von Bonin M, Schönefeldt C, Mair S, Plodeck V, Laniado M, Weiss G, Schetelig J, Ehninger G, Theurl I, Bornhäuser M, Platzbecker U. Clin Cancer Res; 2012 Dec 01; 18(23):6460-8. PubMed ID: 22991415 [Abstract] [Full Text] [Related]
11. Myocardial iron loading by magnetic resonance imaging T2* in good prognostic myelodysplastic syndrome patients on long-term blood transfusions. Chacko J, Pennell DJ, Tanner MA, Hamblin TJ, Wonke B, Levy T, Thomas PW, Killick SB. Br J Haematol; 2007 Sep 01; 138(5):587-93. PubMed ID: 17610536 [Abstract] [Full Text] [Related]
12. Influence of pretransplantation serum ferritin on nonrelapse mortality after myeloablative and nonmyeloablative allogeneic hematopoietic stem cell transplantation. Kataoka K, Nannya Y, Hangaishi A, Imai Y, Chiba S, Takahashi T, Kurokawa M. Biol Blood Marrow Transplant; 2009 Feb 01; 15(2):195-204. PubMed ID: 19167679 [Abstract] [Full Text] [Related]
13. Absence of cardiac siderosis by MRI T2* despite transfusion burden, hepatic and serum iron overload in Lebanese patients with sickle cell disease. Inati A, Musallam KM, Wood JC, Sheikh-Taha M, Daou L, Taher AT. Eur J Haematol; 2009 Dec 01; 83(6):565-71. PubMed ID: 19737308 [Abstract] [Full Text] [Related]
14. Iron Overload in Survivors of Childhood Cancer. Schempp A, Lee J, Kearney S, Mulrooney DA, Smith AR. J Pediatr Hematol Oncol; 2016 Jan 01; 38(1):27-31. PubMed ID: 26422286 [Abstract] [Full Text] [Related]
15. Iron overload manifesting as apparent exacerbation of hepatic graft-versus-host disease after allogeneic hematopoietic stem cell transplantation. Kamble RT, Selby GB, Mims M, Kharfan-Dabaja MA, Ozer H, George JN. Biol Blood Marrow Transplant; 2006 May 01; 12(5):506-10. PubMed ID: 16635785 [Abstract] [Full Text] [Related]
16. A magnetic resonance imaging study of iron overload in hemopoietic stem cell transplant recipients with increased ferritin levels. Au WY, Lam WM, Chu WC, Tam S, Wong WK, Pennell DJ, Lie AK, Liang R. Transplant Proc; 2007 Dec 01; 39(10):3369-74. PubMed ID: 18089387 [Abstract] [Full Text] [Related]
17. Liver iron content assessment by routine and simple magnetic resonance imaging procedure in highly transfused patients. Rose C, Vandevenne P, Bourgeois E, Cambier N, Ernst O. Eur J Haematol; 2006 Aug 01; 77(2):145-9. PubMed ID: 16608501 [Abstract] [Full Text] [Related]
18. Serum ferritin is not a reliable predictor to determine iron overload in thalassemia major patients post-hematopoietic stem cell transplantation. Jarisch A, Salzmann-Manrique E, Cario H, Grosse R, Soerensen J, Fischer R, Schulz A, Hammerstingl R, Wunderlich A, Bader P. Eur J Haematol; 2018 Dec 01; 101(6):791-797. PubMed ID: 30187571 [Abstract] [Full Text] [Related]
19. Magnetic resonance imaging in the evaluation of iron overload in patients with beta thalassaemia and sickle cell disease. Voskaridou E, Douskou M, Terpos E, Papassotiriou I, Stamoulakatou A, Ourailidis A, Loutradi A, Loukopoulos D. Br J Haematol; 2004 Sep 01; 126(5):736-42. PubMed ID: 15327528 [Abstract] [Full Text] [Related]
20. Levels of non-transferrin-bound iron as an index of iron overload in patients with thalassaemia intermedia. Taher A, Musallam KM, El Rassi F, Duca L, Inati A, Koussa S, Cappellini MD. Br J Haematol; 2009 Sep 01; 146(5):569-72. PubMed ID: 19604239 [Abstract] [Full Text] [Related] Page: [Next] [New Search]